TP53 and colorectal cancer: Focusing on the most commonly altered colorectal cancer driver pathways, we observed a subset of polyps with concurrent oncogenic/likely oncogenic mutations according to OncoKB (25) that affect high-risk carcinogenesis pathways of Wnt/b-catenin, RTK-RAS, or p53 (34).